BIOSIMILARS:

ARE YOU READY?

 
Click Here to watch our demo. 
Or scroll down to read articles from Specialty Pharma Journal about Premier’s integrated approach to pharmacy management.

Biosimilars Success in the US: Will Physicians Rule the Road?

As the high cost of new biologic medicines sends U.S. healthcare costs soaring, payers are anxiously anticipating the introduction of biosimilar medicines – biological products, approved by FDA because they are highly similar to an already FDA-approved biological product. However, there is one stakeholder whose influence over biosimilar adoption may be underestimated. CONTINUE READING...

Who’s Teaching Whom in the World of Biosimilars? The Rise of Patient Education

As consumers begin to adapt to the high cost of biologic medicines and their biosimilar counterparts, there may be a shift in education, with patients – not providers – leading the way. CONTINUE READING...

More than a GPO – Premier’s Efforts in Transforming Healthcare

While Premier, Inc. is widely known for operating one of the nation’s largest group purchasing organizations (GPOs) by volume, many may be unaware of the additional suite of valuable services that the company provides to its members to improve the health of communities. CONTINUE READING...

Tell me more about how Premier is addressing current trends, issues and challenges facing specialty pharmacy today.